Heterogeneity Mediated System Complexity: The Ultimate Challenge for Studying Common and Complex Diseases

The Value of Systems and Complexity Sciences for Healthcare

Volumn , Issue , 2016, Pages 107-120

  Heng, Henry H ^a   Horne, Steven D ^a   Stevens, Joshua B ^a   Abdallah, Batoul Y ^a   Liu, Guo ^a   Chowdhury, Saroj K ^b   Bremer, Steven W ^a   Zhang, Kezhong ^a   Ye, Christine J ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b John Dingell VA Medical Center   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Cellular Evolution; Chronic Fatigue Syndrome; Chronic Fatigue Syndrome Patient; System Inheritance; Unstable Genome

Indexed keywords

EID: 85120044417     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-26221-5_9     Document Type: Chapter

References (47)

1. Davidoff F. Heterogeneity is not always noise: lessons from improvement. JAMA. 2009;302(23):2580–86.
2. Heng HH. The conflict between complex systems and reductionism. JAMA. 2008;300(13):1580–81.
3. Heng HH, et al. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol. 2009;220(3):538–47.
4. Heppner GH. Tumor heterogeneity. Cancer Res. 1984;44(6):2259–65.
5. Heng HH. The genome-centric concept: resynthesis of evolutionary theory. BioEssays. 2009;31(5): 512–25.
6. Ye CJ, et al. The dynamics of cancer chromosomes and genomes. Cytogenet Genome Res. 2007; 118(2–4):237–46.
7. Heng HH, et al. Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution. Cancer Metastasis Rev. 2013;32(3–4):325–40.
8. Heng HH, et al. Evolutionary mechanisms and diversity in cancer. Adv Cancer Res. 2011;112:217–53.
9. Heng HH, et al. The evolutionary mechanism of cancer. J Cell Biochem. 2010;109(6):1072–84.
10. Heng HH, et al. Cancer progression by non-clonal chromosome aberrations. J Cell Biochem. 2006;98(6):1424–35.
11. Heng HH, et al. Clonal and non-clonal chromosome aberrations and genome variation and aberration. Genome. 2006;49(3):195–204.
12. Heng HH. Cancer genome sequencing: the challenges ahead. Bioessays. 2007;29(8):783–94.
13. Nesse RM. How is Darwinian medicine useful? West J Med. 2001;174(5):358–60.
14. Podlaha O, et al. Evolution of the cancer genome. Trends Genet. 2012;28(4):155–63.
15. Heng HH. Debating cancer: the paradox in cancer research. Singapore: World Scientific Publishing Company; 2015.
16. Heng HH. Missing heritability and stochastic genome alterations. Nat Rev Genet. 2010;11(11):813.
17. Yurov YB, et al. X chromosome aneuploidy in the Alzheimer’s disease brain. Mol Cytogenet. 2014;7(1):20.
18. Heng HH, et al. Karyotype heterogeneity and unclassified chromosomal abnormalities. Cytogenet Genome Res. 2013;139(3):144–57.
19. Heng HH, et al. Decoding the genome beyond sequencing: the new phase of genomic research. Genomics. 2011;98(4):242–52.
20. Wahab MA, et al. Elevated chromosome translocation frequencies in New Zealand nuclear test veterans. Cytogenet Genome Res. 2008;121(2):79–87.
21. Horne SD, Chowdhury SK, Heng HH. Stress, genomic adaptation, and the evolutionary tradeoff. Front Genet. 2014;5:92.
22. Zhang K, et al. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. J Clin Invest. 2005;115(2):268–81.
23. Astolfi PA, Salamini F, Sgaramella V. Are we genomic mosaics? Variations of the genome of somatic cells can contribute to diversify our phenotypes. Curr Genomics. 2010;11(6):379–86.
24. Duncan AW. Aneuploidy, polyploidy and ploidy reversal in the liver. Semin Cell Dev Biol. 2013;24(4):347–56.
25. Duncan AW, et al. Aneuploidy as amechanism for stress-induced liver adaptation. J Clin Invest. 2012; 122(9):3307–15.
26. Horne SD, et al. Genome constraint through sexual reproduction: application of 4D-Genomics in reproductive biology. Syst Biol Reprod Med. 2013;59(3):124–30.
27. Dewhurst SM, et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 2014;4(2):175–85.
28. Duesberg P, et al. The chromosomal basis of cancer. Cell Oncol. 2005;27(5–6):293–318.
29. Heng HH. Bio-complexity: challenging reductionism. In: Sturmberg JP, Martin CM, editors. Handbook on systems and complexity in health. New York: Springer; 2013. p. 193–208.
30. Gorelick R, Heng HH. Sex reduces genetic variation: a multidisciplinary review. Evolution. 2011;65(4):1088–98.
31. Heng HH. Elimination of altered karyotypes by sexual reproduction preserves species identity. Genome. 2007;50(5):517–24.
32. Wilkins AS, Holliday R. The evolution of meiosis from mitosis. Genetics. 2009;181(1):3–12.
33. Horne SD, Pollick SA, Heng HH. Evolutionary mechanism unifies the hallmarks of cancer. Int J Cancer 2015;136(9):2012–21.
34. Heng HH, et al. Stochastic cancer progression driven by non-clonal chromosome aberrations. J Cell Physiol. 2006;208(2):461–72.
35. Ye CJ, et al. Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer. J Cell Physiol. 2009;219(2):288–300.
36. Heng HH. Karyotypic Chaos, A form of non-clonal chromosome aberrations, plays a key role for cancer progression and drug resistance. In: FASEB: nuclear structure and cancer. Saxtons River, Vermont: Vermont Academy; 2007.
37. Heng HH, et al. Genetic and epigenetic heterogeneity in cancer: the ultimate challenge for drug therapy. Curr Drug Targets. 2010;11(10):1304–16.
38. Gatenby RA, et al. Adaptive therapy. Cancer Res. 2009;69(11):4894–903.
39. Liu G, et al. Genome chaos: survival strategy during crisis. Cell Cycle. 2014;13(4):528–37.
40. Xu J, et al. Molecular cytogenetics of autism. Curr Genomics. 2004;5(4):347–64.
41. Iourov IY, Vorsanova SG, Yurov YB. Chromosomal mosaicism goes global. Mol Cytogenet. 2008;1:26.
42. Kinne RW, et al. Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases. Arthritis Res. 2001;3(5):319–30.
43. Heng HH, Stevens JB, Liu G, Bremer SW, Ye CJ. Imaging genome abnormalities in cancer research. Cell Chromosome. 2004;3:1.
44. Research Advisory Committee on Gulf War Veterans’ Illnesses, Gulf War Illness and the Health of Gulf War Veterans: Research Update and Recommendations. Boston: U.S. Government Printing Office; 2009–2013, 2014.
45. Ye CJ, Stevens JB, Liu G, Ye KJ, Yang F, Bremer SW, Heng HH. Combined multicolor-FISH and immunostaining. Cytogenet Genome Res. 2006;114(3–4):227–34.
46. Stevens JB, Liu G, Bremer SW, Ye KJ, Xu W, Xu J, Sun Y, Wu GS, Savasan S, Krawetz SA, Ye CJ, Heng HH. Mitotic cell death by chromosome fragmentation. Cancer Res. 2007;67(16):7686–94.
47. Heng HH. The contribution of genomic heterogeneity. Preface Cytogenet Genome Res. 2013;139(3):141–43